CINACALCET IN TREATMENT OF HYPERPARATHYROIDISM IN RECIPIENTS OF RENAL GRAFT
Aim. Evaluate the efficacy and safety of cinacalcet in the treatment of hyperparathyroidism (HPT) in renal transplant recipients. Materials and methods. During the year, three patients with satisfactory functioning kid- ney transplant (glomerular filtration rate − GFR 44–80 ml/min) and HPT (parathyr...
Saved in:
| Main Authors: | O. N. Vetchinnikova, E. O. Shcherbakova, E. Y. Polyakova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2014-05-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/65 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and risk factors of post-kidney transplant hyperparathyroidism: a single-center study
by: O. N. Vetchinnikova, et al.
Published: (2020-07-01) -
Clinical observation of Cinacalcet in the treatment of secondary hyperparathyroidism in hemodialysis patients
by: ZHANG Xin, et al.
Published: (2018-01-01) -
A Meta-analysis of Cinacalcet in the treatment of dialysis patients with secondary hyperparathyroidism
by: LV Yuan, et al.
Published: (2018-01-01) -
Hyperparathyroidism in kidney transplant candidates and postoperative parathyroid gland function in recipients
by: O. N. Vetchinnikova
Published: (2024-07-01) -
Meta-analysis of the efficacy and safety of cinacalcet combined with active vitamin D in the treatment of secondary hyperparathyroidism in dialysis patients with end-stage renal disease
by: DAI Chao-run, et al.
Published: (2020-01-01)